Strides gets USFDA approval for Gabapentin Tablets USP, 600 mg and 800 mg EP News Bureau Mar 5, 2024 Gabapentin tablets will be manufactured at the company’s facility in Puducherry
Zydus gets USFDA nod for Gabapentin tablets (once-daily), 300 mg and 600 mg Lakshmipriya Nair Jan 25, 2024 Gabapentin is indicated for the management of Postherpetic Neuraligia (PHN)
Granules India gets ANDA approval for Gabapentin tablets EP News Bureau Mar 29, 2023 Gabapentin tablets are indicated for management of postherpetic neuralgia in adults; and as an adjunctive therapy in the treatment…
Zydus gets tentative nod from USFDA for Gabapentin Tablets, 300 mg and 600 mg EP News Bureau Feb 20, 2023 Gabapentin tablets are indicated for the management of Postherpetic Neuralgia (PHN)